Protein Language Models Global Market Report 2026

Protein language models are artificial intelligence systems developed to interpret, encode, and forecast protein characteristics by identifying patterns within amino acid sequences. These systems support protein engineering, functional analysis, and the exploration of molecular interactions. They accelerate scientific research and innovation by offering computational understanding of protein dynamics.

The primary components of protein language models include software, hardware, and services. Software refers to platforms that allow organizations to analyze protein sequences, forecast structures, and simulate biological behaviors using advanced machine learning and language modeling approaches. These solutions are deployed through cloud-based and on-premises models based on infrastructure and computational demands. The applications include drug discovery, protein design, disease identification, functional annotation, and other scientific uses. The end users include pharmaceutical and biotechnology companies, academic and research institutions, healthcare providers, and others.

Tariffs are impacting the protein language models market by raising the cost of imported high performance computing hardware and specialized processors used for model training. Increased duties on servers, accelerators, and advanced chips are elevating infrastructure expenses for platform providers and research organizations. Cloud and on premises deployment segments that depend on imported compute equipment are the most affected. North america and asia pacific markets with heavy AI hardware imports are seeing cost pressure and delayed capacity expansion. Service providers are adjusting pricing and shifting workloads to optimized environments. At the same time, tariffs are encouraging regional hardware sourcing and local AI infrastructure development. This supports domestic suppliers and strengthens local compute ecosystems.

The protein language models market research report is one of a series of new reports from The Business Research Company that provides protein language models market statistics, including protein language models industry global market size, regional shares, competitors with a protein language models market share, detailed protein language models market segments, market trends and opportunities, and any further data you may need to thrive in the protein language models industry. This protein language models market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The protein language models market size has grown exponentially in recent years. It will grow from $0.97 billion in 2025 to $1.22 billion in 2026 at a compound annual growth rate (CAGR) of 25.5%. The growth in the historic period can be attributed to growth in genomic sequencing data, rising biopharma research spending, expansion of bioinformatics platforms, increase in protein database availability, early adoption of machine learning in biology.

The protein language models market size is expected to see exponential growth in the next few years. It will grow to $3.05 billion in 2030 at a compound annual growth rate (CAGR) of 25.7%. The growth in the forecast period can be attributed to increasing demand for computational protein design, expansion of AI led drug pipelines, rising need for rapid target identification, growing cross industry AI biology collaborations, higher investment in AI life science startups. Major trends in the forecast period include rising use of sequence based protein representation models, expansion of cloud hosted protein modeling platforms, growing demand for protein annotation services, increase in api based bioinformatics toolkits, higher adoption of AI driven drug discovery workflows.

The expansion of precision medicine and personalized therapeutics is expected to drive the growth of the protein language models market in the coming years. Precision medicine and personalized therapeutics refer to healthcare approaches that tailor treatments to individual patient characteristics, such as genetic makeup, biomarkers, and disease profiles, to improve treatment effectiveness and reduce adverse outcomes. Growth in precision medicine and personalized therapeutics is driven by increasing regulatory approvals and research focused on targeted therapies that address specific biological pathways rather than one-size-fits-all treatments. Protein language models support precision medicine by enabling detailed analysis of protein sequences and structures, helping researchers identify therapeutic targets, predict drug responses, and design patient-specific biological treatments more efficiently. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based not-for-profit organization, in 2023, the Food and Drug Administration (FDA) approved 16 new personalized therapies for rare disease patients, marking a sharp increase from six approvals in 2022. Therefore, the expansion of precision medicine and personalized therapeutics is propelling the growth of the protein language models market.

The rising adoption of AI-driven drug discovery is expected to drive the growth of the protein language models market in the coming years. AI-driven drug discovery leverages artificial intelligence to accelerate the identification, design, and optimization of drug candidates through advanced analysis of large-scale biological and chemical data. Adoption of AI in drug discovery is increasing due to its ability to accelerate target identification, optimize candidate selection, and improve research efficiency compared to traditional methods. Protein language models support drug discovery by using deep learning architectures to analyze protein sequences, predict structure-function relationships, and identify meaningful patterns that inform target selection and candidate optimization. For example, in January 2025, according to the World Economic Forum, a Switzerland-based non-profit organization, approximately 30 percent of new drugs are discovered using AI technologies. Therefore, the rising adoption of AI-driven drug discovery is propelling the growth of the protein language models market.

Organizations operating in the protein language models market are focusing on developing advanced AI-driven protein language models to improve protein sequence analysis and accelerate drug discovery and biological research. An AI-driven protein language model uses artificial intelligence trained on large-scale protein sequences to predict, interpret, and generate protein structures and functions that accelerate protein engineering, mutation assessment, and the development of new therapeutic solutions. For example, in September 2024, Ginkgo Bioworks Holdings, Inc., a US-based biotechnology company, launched a Protein Large Language Model and Model API built on Google Cloud technology. The solution is trained on Ginkgo's proprietary protein dataset and hosted on Vertex AI, enabling enterprises and individual researchers to perform advanced protein sequence analysis and improve pattern recognition, thereby accelerating drug development and biological research workflows.

Major companies operating in the protein language models market are Google LLC, Meta Platforms Inc., Pfizer Inc., Novartis AG, AstraZeneca PLC, NVIDIA Corporation, Owkin Inc., Generate Biomedicines Inc., Recursion Pharmaceuticals Inc., BenevolentAI Limited, Exscientia plc, Dyno Therapeutics Inc., Atomwise Inc., ProteinQure Inc., Cradle Bio B.V., Profluent Bio Inc., BioMap (Beijing) Intelligence Technology Co. Ltd., EvolutionaryScale Inc., Isomorphic Labs Limited, Insilico Medicine Inc., AbSci Corporation, Peptone Ltd., and Valence Labs Inc.

North America was the largest region in the protein language models market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein language models market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the protein language models market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The protein language models market consists of revenues earned by entities by providing services such as model training and fine-tuning, protein sequence annotation, structure and function prediction services, AI-driven drug discovery, cloud-based model hosting, bioinformatics consulting services, and custom model development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein language models market also includes sales of embedding generation tools, bioinformatics platforms, protein structure prediction tools, model training frameworks, and application programming interface toolkits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Protein Language Models Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses protein language models market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for protein language models ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The protein language models market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Software; Hardware; Services
• 2) By Deployment Mode: On-Premises; Cloud
• 3) By Application: Drug Discovery; Protein Engineering; Disease Diagnosis; Functional Annotation; Other Applications
• 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Healthcare Providers; Other End-Users
• Subsegments:
• 1) By Software: Protein Sequence Analysis Platforms; Model Training And Fine Tuning Tools; Protein Structure Prediction Software; Protein Function Annotation Tools; Bioinformatics Integration Platforms
• 2) By Hardware: High Performance Computing Systems; Graphics Processing Hardware; Tensor Processing Hardware; Data Storage And Processing Systems; Cloud Based Computing Infrastructure
• 3) By Services: Consulting And Advisory Services; Custom Model Development Services; System Integration Services; Managed And Support Services; Training And Knowledge Transfer Services
• Companies Mentioned: Google LLC; Meta Platforms Inc.; Pfizer Inc.; Novartis AG; AstraZeneca PLC; NVIDIA Corporation; Owkin Inc.; Generate Biomedicines Inc.; Recursion Pharmaceuticals Inc.; BenevolentAI Limited; Exscientia plc; Dyno Therapeutics Inc.; Atomwise Inc.; ProteinQure Inc.; Cradle Bio B.V.; Profluent Bio Inc.; BioMap (Beijing) Intelligence Technology Co. Ltd.; EvolutionaryScale Inc.; Isomorphic Labs Limited; Insilico Medicine Inc.; AbSci Corporation; Peptone Ltd.; and Valence Labs Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.